Integrator Complex Subunit 13 (INTS13) (AA 50-254) Antikörper
Kurzübersicht für Integrator Complex Subunit 13 (INTS13) (AA 50-254) Antikörper (ABIN7569775)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 50-254
-
Verwendungszweck
- Anti-Human INTS13 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human INTS13 (Ser50-His254).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
-
: "Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma." in: Heliyon, Vol. 10, Issue 9, pp. e30244, (2024) (PubMed).
-
-
- Integrator Complex Subunit 13 (INTS13)
-
Andere Bezeichnung
- INTS13
-
Hintergrund
- Protein asunder homolog, C12orf11, Cell cycle regulator Mat89Bb homolog, Integrator complex subunit 13, INTS13, Germ cell tumor 1, Sarcoma antigen NY-SAR-95, GCT1, ASUN
-
UniProt
- Q9NVM9
Target
-